On September 5, 2023, BioCardia, a cutting-edge company specializing in regenerative medicine, unveiled the latest findings from the phase III ...
BioCardia, a leading company in the field of regenerative medicine, has recently made a significant announcement regarding its phase 3 ...
On September 5, 2023, Biocardia made an exciting announcement regarding the interim efficacy results of their groundbreaking Phase 3 CardiAMP ...
CarGurus, the popular online automotive marketplace, has seen a surge in its stock prices following the release of its impressive ...
BioCardia (NASDAQ: BCDA) is gearing up to unveil its quarterly earnings report on August 9, 2023. Industry analysts predict that ...
On July 24, 2023, Joseph Pantginis, an analyst at HC Wainwright & Co., expressed his positive outlook on BioCardia (NASDAQ: ...
On July 24, 2023, BioCardia, a leading company in the field of regenerative medicine, received an important recommendation from the ...